- Home
- ADPT
as 02-21-2025 4:00pm EST
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | SEATTLE |
| Market Cap: | 1.2B | IPO Year: | 2019 |
| Target Price: | $9.10 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.28 - $8.95 | Next Earning Date: | 02-11-2025 |
| Revenue: | $178,957,000 | Revenue Growth: | 5.10% |
| Revenue Growth (this year): | 20.07% | Revenue Growth (next year): | 25.27% |
Latest Adaptive Biotechnologies Corporation News
ADPT Breaking Stock News: Dive into ADPT Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
Adaptive Biotechnologies Insider Sold Shares Worth $3,985,754, According to a Recent SEC Filing
TipRanks
8 days ago
Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank
Simply Wall St.
9 days ago
Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations
Zacks
10 days ago
Adaptive Biotechnologies (ADPT) Moves to Buy: Rationale Behind the Upgrade
Thomson Reuters StreetEvents
10 days ago
Q4 2024 Adaptive Biotechnologies Corp Earnings Call
Zacks
10 days ago
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
GuruFocus.com
10 days ago
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ...
Zacks
10 days ago
Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Compare ADPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ADPT Adaptive Biotechnologies Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.